• Antleron NV

Manufacturing living body parts for the patient

From growing human tissues and organs using stem cells to curing several unmet medical needs with cell therapies, regenerative medicine is a hotbed of innovative research worldwide. It is believed by many, to be the future of medicine and healthcare. Interest in the field is driven by its potential to offer solutions for several unmet medical needs such as cancers, diabetes, congestive heart failure, Parkinson’s disease, Alzheimer’s disease and spinal cord injuries. And by the need for a sustainable healthcare system.

Regenerative medicine aims to give patients a therapy that has a regenerative capacity. A molecule, cells, a biomaterial, a piece of tissue or a whole organ, with the intention not to slow down a disease or keep it stable, but to give the body a trigger to regenerate. A trigger that will restore the injured or diseased body (part) in its original state. From a science and technology point of view, regenerative medicine is at the intersection of biology, physics, chemistry, mechanics and engineering. It embraces several research areas, such as cell therapy, tissue engineering, biomaterials engineering, growth factors, transplantation science, artificial intelligence, quality and manufacturing technologies. It’s a very broad field looking into medical devices, artificial organs, tissue engineering and biomaterials, cell therapies and drug development technologies.

“Today, regenerative medicine is in its infancy, right at the beginning”, says Jan Schrooten, co-founder and CEO at Antleron and coordinator of the Regenerative Medicine Innovation Platform (RegMed), an open community to drive regenerative medicine towards a real industry with clinical applications and socio-economical return.

Read the full publication: https://moonshot4life.com/manufacturing-living-body-parts-for-the-patient/